Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: time to revise the guidelines for drug‐resistance testing in leprosy? - Narang, T.; Kamat, D.; Thakur, V.; Lavania, M.; Singh, I.; Ahuja, M.; Dogra, S. (Clinical & Experimental Dermatology, 2022)